Liver damage is a well-recognised complication of gene therapies based on adeno-associated virus (AAV) vectors, and other ...

Streeting has also promised to reduce the time it takes to get clinical trials approved by cutting red tape, pointing out ...

Jeremy Skillington, CEO of LSE-listed Poolbeg Pharma, which has programmes targeting areas of high unmet medical need, ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, the world's second-largest pharma market. The new unit in Beijing – the ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

9 June 2025: The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...